Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists
- 1 May 2006
- journal article
- case report
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 21 (5), 729-732
- https://doi.org/10.1007/s00467-006-0070-1
Abstract
We report renal lesions observed in a foetus exposed throughout pregnancy to angiotensin II type I (AT 1) receptor antagonists. The mother suffered from essential hypertension and was treated with Cozaar (losartan 50 mg). Autopsy examination of the foetus revealed severe renal lesions, including tubular dysgenesis, hypertrophy of the endothelial and medial cells lining the arterial and arteriolar walls, hyperplasia of the juxtaglomerular apparatus and poorly developed vasa recta. Similar lesions have already been observed in foetuses of women treated with angiotensin-converting enzyme antagonists and also in foetuses and neonates of animals undergoing experimental blockade of the renin-angiotensin system. The purpose of this report is to describe structural lesions observed in the kidneys, and, particularly, vascular lesions. Our results suggest that the use of AT 1 receptor antagonists during pregnancy may have a severe deleterious effect on kidney development in the foetus.Keywords
This publication has 27 references indexed in Scilit:
- Angiotensin II Regulates Vascular Endothelial Growth Factor via Hypoxia-Inducible Factor-1α Induction and Redox Mechanisms in the KidneyAntioxidants and Redox Signaling, 2005
- TGF-β superfamily members modulate growth, branching, shaping, and patterning of the ureteric budDevelopmental Biology, 2003
- Transforming Growth Factor-β1 Induces Vascular Endothelial Growth Factor Expression in Murine Proximal Tubular Epithelial CellsNephron Experimental Nephrology, 2003
- Role of angiotensin in renal vascular developmentKidney International, 1998
- Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorptionKidney International, 1998
- Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes.JCI Insight, 1998
- Angiotensin‐II Biochemistry and Physiology: Update on Angiotensin‐II Receptor BlockersCardiovascular Drug Reviews, 1997
- Evaluation of the reproductive and developmental toxicity of the AT1‐selective angiotensin II receptor antagonist Losartan in ratsTeratology, 1995
- ACE INHIBITORS IN PREGNANCYThe Lancet, 1989
- CONGENITAL RENAL DYSGENESIS POSSIBLY DUE TO CAPTOPRILThe Lancet, 1989